Marking an important milestone in the development of new cancer treatments, officials from the KU Cancer Center have announced the opening of a Phase I clinical trial using a new ovarian cancer drug developed by KU researchers.

Click It

• 1.Campus Closeup
  
  
• 2.Spencer's Douglas exhibit on display at Smithsonian
• 3.Two new posts to coordinate, boost research technology